How A PET/CT Study Saved A Patient From Unnecessary Thyroid Surgery with a Class III atypical cytology and suspicious AFIRMA classifier.

How A PET/CT Study Saved A Patient From Unnecessary Thyroid Surgery with a Class III atypical cytology and suspicious AFIRMA classifier.

How A PET/CT Study Saved A Patient From Unnecessary Thyroid Surgery with a Class III atypical cytology and suspicious AFIRMA classifier.

50 Y/O female with a large thyroid nodule who was told to have surgery after the FNA was class III atypical cells, and a AFIRMA GSC classifier suspicious.She was told she had a 50% chance of cancer.

She had the nodular goiter for years 2004. She refused surgery and looked for an alternative. After my evaluation I ordered a PET/CT to hel decide if she really had a 50% chance of cancer.

The use of PET/CT use in this type of case can help sort out if there is a high risk of cancer as shown by the FNA, and Afirma classifier tests.

The results of the PET/CT was a low SUV 3.3 for the nodule. Studies have confirmed that SUV < 5 is a good independent risk factor for a benign nodule.

I discussed these results with the patient and told her she had a lower risk of cancer than was stated by the FNA and Afirma. After she again refused surgery with this new better prognosis, she elected for radiofrequency ablation.

If you are told to have surgery based on atypical biopsy and suspicious molecular marker classifier, come for an evaluation. You may have a lower risk of cancer than 50%. You may be a candidate for RFA.

Call me at 310-393-8860 or email to [email protected] for Alicia.

DR.G.

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860